Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Malaysian Genomics Resource Centre Bhd Days Payable?
Malaysian Genomics Resource Centre BhdXKLS:0155 44 Days Payable is 330.78 as of Mar. 2026, which is 936% above its 10-year median of 31.92. GuruFocus rates XKLS:0155 with a GF Score™ of 44/100 and a GF Value™ of RM0.31 (Fairly Valued). The stock has 3 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Malaysian Genomics Resource Centre Bhd ranks better than 86.32% on this metric.
XKLS:0155's Days Payable is ranked better than 86.32% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.64
vs XKLS:0155: 295.68
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Malaysian Genomics Resource Centre Bhd Days Payable Chart
Malaysian Genomics Resource Centre Bhd Annual Data
XKLS:0155 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Malaysian Genomics Resource Centre Bhd Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Days Payable distribution charts can be found below:
* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Days Payable falls into.
Malaysian Genomics Resource Centre Bhd Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Malaysian Genomics Resource Centre Bhd (XKLS:0155) has a Days Payable of 330.78 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. This is 936% above median its historical median of 31.92. Over the past decade, Malaysian Genomics Resource Centre Bhd's Days Payable has ranged from 0.96 to 1,945.18. According to the industry distribution chart, Malaysian Genomics Resource Centre Bhd ranks #26 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 13.7%.
Is Malaysian Genomics Resource Centre Bhd's Days Payable too high?
Malaysian Genomics Resource Centre Bhd's current Days Payable of 330.78 is 936% above median its 10-year median of 31.92. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 1,945.18. The Medical Diagnostics & Research industry median Days Payable is 64.64. Malaysian Genomics Resource Centre Bhd's value of 330.78 is 411.7% above this industry median. Based on the distribution chart, Malaysian Genomics Resource Centre Bhd ranks #26 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Malaysian Genomics Resource Centre Bhd has a GF Score™ of 44/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Malaysian Genomics Resource Centre Bhd's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Malaysian Genomics Resource Centre Bhd ranks #26 out of 190 companies for Days Payable. This places Malaysian Genomics Resource Centre Bhd in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 64.64. Malaysian Genomics Resource Centre Bhd's value of 330.78 is 411.7% above this benchmark. Historically, Malaysian Genomics Resource Centre Bhd's own Days Payable has ranged from 0.96 to 1,945.18 over the past decade. While the company's 10-year median is 31.92 vs. the industry median of 64.64, Malaysian Genomics Resource Centre Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.64, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Malaysian Genomics Resource Centre Bhd's current Days Payable of 330.78 is 411.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Malaysian Genomics Resource Centre Bhd's current Days Payable is 330.78, which is 936% above median its own 10-year median of 31.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malaysian Genomics Resource Centre Bhd stock overvalued right now?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd (XKLS:0155) is currently considered Fairly Valued. The stock's GF Value™ is RM0.31, compared to a current price of RM0.30 — trading 4.8% below its estimated fair value. The current Days Payable is 330.78, which is 936% above median its 10-year median of 31.92 and 411.7% above the Medical Diagnostics & Research industry median of 64.64. Malaysian Genomics Resource Centre Bhd's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Malaysian Genomics Resource Centre Bhd (XKLS:0155), the current Days Payable is 330.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Malaysian Genomics Resource Centre Bhd (XKLS:0155) Overvalued in 2026?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd stock appears to be undervalued.
The current stock price of RM0.30 is trading 4.8% below its estimated GF Value™ of RM0.31.
GuruFocus considers Malaysian Genomics Resource Centre Bhd to be Fairly Valued.
Key valuation signals for XKLS:0155:
Days Payable: 330.78 (936% above median its 10-year median of 31.92)
GF Value™: RM0.31 vs. price of RM0.30 (4.8% below fair value)
Industry Position: 411.7% above the Medical Diagnostics & Research median (#26 of 190)
No single metric tells the full story. See the XKLS:0155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Malaysian Genomics Resource Centre Bhd Business Description
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services and genetic screening services (GSS). The group offerings include precision genetic screening, project-based analysis, and high-quality cell therapy and cosmeceutical products. The reportable segments of the Group derive their revenue from the provision of personalised and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services within the healthcare segment.
44GF Score
Get the complete analysis for XKLS:0155
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0155 has been successfully added to your 
